arrow_back Back Filing freshness 10-K FY 2026 SEC EDGAR

PRECISION OPTICS CORPORATION, INC.

POCI
$4.81 ▼ -0.03 (-0.62%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
16 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
29
Health
Poor
Moderately Bearish
auto_awesome

Analytical Summary

PRECISION OPTICS CORPORATION, INC. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). On the positive side, Debt to Equity remains strong. Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $41.0M
Dividend Yield —
Revenue Growth 65.2% ↗
Op. Margin -11.1% ↗
ROIC -16.2% ↗
FCF / Share $-0.23 ↗
Trailing P/E —
Price / Book 2.6x
FCF Yield —
Debt / Equity 0.07
info Valuation on last close. End-of-day price, Nov 5, 2026.

16-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$31.53M
↑ +65.2% —
Net Income Profit after all expenses
$-3.63M
↑ +37.2% —
Operating Margin Operating profit as % of sales
-11.1%
↑ +61.7% 11th
FCF / Share Free cash flow per share
$-0.23
↑ +58.3% —
Long-Term Debt Long-term obligations
$1.33M
↓ -30.9% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
10
Returns ↓
26
Financial Health ↓
52
Cash Quality ↓
40

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 16 years · 65 quarters